Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(14%)
Results Posted
25%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_4
1
14%
Ph not_applicable
5
71%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (16.7%)
N/A5 (83.3%)

Trials by Status

completed457%
terminated114%
recruiting114%
not_yet_recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
7